URMC / Research / Clinical Trials / Study Details Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis Research Question:Do the drug PF-06651600 or PF-06700841 treat ulcerative colitis.Basic Study Information Purpose:Ulcerative colitis is an inflammatory bowel disease (IBD) that causes long-lasting inflammation and ulcers (sores) in your digestive tract. Ulcerative colitis affects the innermost lining of your large intestine (colon) and rectum. The purpose of this study is to determine whether PF-06651600 and PF-06700841 are effective in treatment of moderate to severe ulcerative colitis. Location: University of Rochester Medical CenterStudy Contact InformationStudy Coordinator: Pfizer CT.gov Call CenterEmail: ClinicalTrials.gov_Inquiries@pfizer.com Additional Study Details Contact This Study First Name * This field is required Middle Name Last Name * This field is required Phone Number Email I agree to be contacted by The University of Rochester Medical Center regarding participation in this study. *You must agree to be contacted to continue. Please call me during the day. Please call me during the evening. Message Thank you for contacting us. People like you are helping URMC make our community and world a healthier place. We sincerely appreciate your effort. A member of our research team will be in touch with you. URMC / Wilmot Cancer Institute /Research / Clinical Trials / Study Details Trial Not Found The study you are looking for is not active at this time. Return to Search